79% effective: AstraZeneca Covid vaccine gets a shot in the arm
Drugmaker intends to request US emergency authorisation in the coming weeks.
AstraZeneca’s Covid-19 vaccine performed better than expected in a major late-stage trial, potentially paving the way for its emergency authorisation in the United States and bolstering confidence in the shot after numerous setbacks in Europe.
The drugmaker said on Monday that interim data from trials in Chile, Peru and the United States found the vaccine, developed in conjunction with Oxford University, was 79 per cent effective in preventing symptomatic Covid-19 and, crucially, posed no increased risk of blood clots. It intends to request US emergency authorisation in the coming weeks.
More than a dozen European countries, including Germany and France, had halted use of the AstraZeneca vaccine earlier this month after reports linked it to blood clots in a very small number of people.
Supreme Committee to reduce employees at workplaces by 50% from April ... READ MORE
This takes the rate of doses per 100 people to 84.84. READ MORE
Many employees in the SME sectors are still waiting for the salary... READ MORE
Over 37.8 million tests have been conducted across the country to... READ MORE
The plan is to have 4,000 self-driving vehicles by 2030. READ MORE
More than 1.5 million meals have already been donated a day after the ... READ MORE
The new cases were detected through 193,896 additional tests. READ MORE
Yusuff Ali landed in Abu Dhabi on a special aircraft and is resting... READ MORE